Gontivimab (ALX-0171; VR-465) is a potent nanobody targeting the respiratory syncytial virus (RSV) prefusion F protein, exhibiting a dissociation constant (K_D) of 0.113 nM. This high-affinity binding is indicative of its robust antiviral properties. Gontivimab has demonstrated efficacy in reducing viral load in both nasal and pulmonary tissues, highlighting its potential for therapeutic applications in RSV infections.
Gontivimab (ALX-0171; VR-465) is a potent nanobody targeting the respiratory syncytial virus (RSV) prefusion F protein, exhibiting a dissociation constant (K_D) of 0.113 nM. This high-affinity binding is indicative of its robust antiviral properties. Gontivimab has demonstrated efficacy in reducing viral load in both nasal and pulmonary tissues, highlighting its potential for therapeutic applications in RSV infections.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
